Drug trial aims to stop bleeding, speed recovery from common prostate surgery
NCT ID NCT07460518
Summary
This study is testing if a drug called tranexamic acid (TXA) can reduce bleeding during a common prostate surgery for enlarged prostate (BPH). It will involve 80 men who are randomly given either the drug or a placebo (inactive solution) before their surgery. The main goal is to see if the drug helps patients lose less blood during the operation and have better blood counts afterward, which could lead to a faster recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mohammed V Military Teaching Hospital
Rabat, Rabat, 10180, Morocco
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.